Following reports of delays in fulfillment of orders from a Thai facility owned by the country’s powerful king, AstraZeneca said it is working closely with Southeast Asian governments to ensure the COVID-19 vaccine is delivered “as fast as feasible.”
Malaysia and Taiwan are the latest countries in the region to say they expect delays in AstraZeneca vaccine delivery made in Thailand.
“In the next weeks, distribution to other Southeast Asian nations, including Malaysia, will begin,” the business said in an e-mail to Reuters.
A Philippine presidential adviser claimed last week that the initial delivery to the Philippines, which had been promised 17 million doses, had been lowered and postponed by several weeks.
Thailand received 1.8 million locally produced dosages and 200,000 imported from South Korea last week, with a total of six million doses expected in June.
In the past, AstraZeneca has had production and delivery issues in various parts of the world. A deal to set up production in Taiwan fell through, and the European Union has filed a legal challenge over a supply contract.